Related Experiment Video
Updated: Dec 31, 2025

CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans
Published on: November 14, 2018
CRISPR-Cas9-mediated genome editing in vancomycin-resistant Enterococcus faecium
Vincent de Maat1, Paul B Stege1, Mark Dedden1
1Department of Medical Microbiology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.
Abstract:
The Gram-positive bacterium Enterococcus faecium is becoming increasingly prevalent as a cause of hospital-acquired, antibiotic-resistant infections. A fundamental part of research into E. faecium biology relies on the ability to generate targeted mutants but this process is currently labour-intensive and time-consuming, taking 4 to 5 weeks per mutant. In this report, we describe a method relying on the high recombination rates of E. faecium and the application of the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Cas9 genome editing tool to more efficiently generate targeted mutants in the E. faecium chromosome. Using this tool and the multi-drug resistant clinical E. faecium strain E745, we generated a deletion mutant in the lacL gene, which encodes the large subunit of the E. faeciumβ-galactosidase. Blue/white screening using 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) could be used to distinguish between the wild-type and lacL deletion mutant. We also inserted two copies of gfp into the intrinsic E. faecium macrolide resistance gene msrC to generate stable green fluorescent cells. We conclude that CRISPR-Cas9 can be used to generate targeted genome modifications in E. faecium in 3 weeks, with limited hands-on time. This method can potentially be implemented in other Gram-positive bacteria with high intrinsic recombination rates.
Insights
Researchers developed a faster method using CRISPR-Cas9 to create genetic mutants in Enterococcus faecium, a bacterium causing hospital infections. This new technique significantly reduces the time needed for genetic modification, aiding further research into antibiotic resistance.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Enterococcus faecium is a growing cause of hospital-acquired infections.
- Antibiotic resistance in E. faecium poses a significant public health threat.
- Generating targeted mutants in E. faecium is crucial for research but is currently slow and labor-intensive.
Purpose of the Study:
- To develop a more efficient method for generating targeted genome modifications in E. faecium.
- To adapt the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Cas9 system for use in E. faecium.
Main Methods:
- Utilized the high recombination rates of E. faecium.
- Applied the CRISPR-Cas9 genome editing tool.
- Generated a lacL deletion mutant and inserted green fluorescent protein (GFP) into the msrC gene.
Main Results:
- Successfully generated targeted genome modifications in E. faecium.
- Reduced the time required for mutant generation from 4-5 weeks to 3 weeks.
- Demonstrated the ability to create both gene deletions and insertions using CRISPR-Cas9.
- Distinguished wild-type from mutant strains using blue/white screening with X-gal.
- Created stable green fluorescent E. faecium cells by inserting GFP.
Conclusions:
- CRISPR-Cas9 is an efficient tool for generating targeted genome modifications in E. faecium.
- The developed method significantly reduces the time and labor required for mutant generation.
- This approach has the potential for application in other Gram-positive bacteria with high recombination rates.
More Related Videos
07:46CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
11:35Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination